Indeed, as reported in thyroid and other cancer types, TERT promoter mutations lead to an increase in TERT mRNA expression levels as compared to wild‐type (WT) TERT. 20, 21, 22, 23, 24, 25. This evidence concerns the gene TERT and thyroid gland disorder.